mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8:605-619. Objective: To describe and evaluate relationships between body mass index (BMI) and blood pressure, cholesterol, high-density lipoprotein-cholesterol (HDL-C), and hypertension and dyslipidemia.
Introduction
Obesity is an independent risk factor for cardiovascular disease, type 2 diabetes, gallbladder disease, cancers at several sites, osteoarthritis, and total mortality (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . A recent report described associations between overweight and obesity and the prevalence of chronic conditions including high blood pressure and high blood cholesterol levels in National Health and Nutrition Examination Survey (NHANES) III data (19) . Associations between obesity and high blood pressure, high blood cholesterol, and low levels of high density lipoprotein-cholesterol (HDL-C) have been shown in men and women and in diverse race/ethnic groups (6 -19) .
The prevalence of overweight and obesity is increasing, and obesity is now estimated to be the second leading cause of preventable death after cigarette smoking in the United States (21) (22) (23) (24) . By contrast, national trends in blood pressure and hypertension and in blood cholesterol and hypercholesterolemia over the past two decades have been favorable (23, [25] [26] [27] [28] . Levels of HDL-C increased slightly although not consistently in older adults (27, 28) . These favorable trends have probably not achieved their full potential because of the increasing prevalence of overweight. The increased prevalence of over-weight among children and adolescents (29) may affect adversely future trends of hypertension and high blood cholesterol.
Although the terms overweight and obesity are often used interchangeably, overweight refers to an excess of body weight compared with height; obesity refers to an excess of body fat. In populations in which high levels of adiposity are common, such as the population of the United States, excess body fat or adiposity is highly correlated with body weight (30) . Thus, under these conditions, body mass index (BMI) is a convenient and valid measure of adiposity. BMI is calculated by dividing the weight in kilograms by the square of height in meters (kg/m 2 ). A recent review supports the use of BMI in clinical practice (31, 32) to define overweight (BMI of 25 to 29.9) and obesity (BMI of Ն30).
The present report provides detailed information on the distribution of blood pressure and total cholesterol, and on the prevalence of hypertension and dyslipidemia, in relation to levels of BMI for representative samples of white, black, and Mexican American adults in the United States. It presents new information on relationships between BMI and HDL-C. The results, based on the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) and National Cholesterol Education Program (NCEP) definitions of high blood pressure and high blood cholesterol, are relevant to clinical practice and public health approaches to reducing the burden of overweight, obesity, cardiovascular disease, and related conditions.
Research Methods and Procedures

Data Source
The NHANES are multipurpose health examination surveys that estimate the prevalence of chronic diseases and associated risk factors for representative samples of the civilian, noninstitutionalized population of the United States. The third NHANES survey (NHANES III) was conducted in two 3-year phases between 1988 and 1994. Data for all 6 years of NHANES III are presented here. The survey consisted of an interview and examination in the home and a detailed examination in a mobile examination center. Detailed descriptions of the design and conduct of NHANES have been reported (33, 34) . The cardiovascular component was designed in cooperation with the National Heart, Lung, and Blood Institute. The protocols for measurement of blood pressure, height and weight, and venipuncture and laboratory methods for lipid determinations have been published previously (21, 25, 27 ). An interviewer measured blood pressure three times with the participant resting quietly, sitting in a chair at home. A physician took three additional blood pressure measurements in the mobile examination center. In both venues, blood pressure was measured with a standard sphygmomanometer (W. A. Baum, Copiague, NY). One of four cuff sizes (pediatric, regular adult, large, or thigh) was chosen based on the circumference of the participant's arm, as indicated by the manufacturer's guidelines. Total cholesterol and HDL-C levels were measured in blood specimens obtained during the examination in a mobile examination center. All lipid measurements were based on a single blood determination. Adults were weighed without shoes in a hospital gown with an electronic-load cell scale in kilograms to two decimal places. Height was measured without shoes with a fixed stadiometer and recorded to the nearest millimeter.
Complete data on age and race/ethnicity were available for 8816 men and 10,009 women aged 20 years and older, excluding pregnant women. Approximately 98% of men and women had three to six blood pressure measurements and information on current use of antihypertensive medication, 85% of both sexes had total cholesterol and HDL-C data, and 90% of men and 87% of women had data on BMI. Because of combinations of missing data, sample sizes varied, from 16,681 in Table 1 (only persons with missing BMI were excluded) to 15,645 for the high blood cholesterol model in Table 6 (persons with missing data on BMI, cholesterol, current smoking status, or education were excluded).
Definitions
Four categories of BMI (Ͻ25; 25 to Ͻ27; 27 to Ͻ30; and Ն30 kg/m 2 ) were compared. These categories were selected to correspond to various national and international recommendations to define healthy weight (BMI of 18.5 to 24.9), overweight (BMI of 25 to 29.9), and obesity (BMI of Ն30) (32, (35) (36) (37) (38) (39) . High blood pressure was defined as mean systolic blood pressure Ն140 mm Hg, mean diastolic blood pressure Ն90 mm Hg, or current use of antihypertensive medication (25) . This definition is consistent with the clinical definition of high blood pressure in the JNC VI (40) . The means of three or more blood pressure readings obtained either at home or in the mobile examination center were used in these analyses.
High blood cholesterol was defined as total serum cholesterol Ն240 mg/dL (6.21 mM). Low HDL-C was defined as Ͻ35 mg/dL (0.91 mM) in men and Ͻ45 mg/dL (1.16 mM) in women (27) to reflect the higher mean in women than men. This definition is different from that used by NCEP's second Adult Treatment Panel (41) .
Dyslipidemia was defined in some analyses as a ratio of total cholesterol to HDL-C of Ն4.5. The same definition was used for men and women.
Current smokers had smoked 100 cigarettes or more in their lifetime and smoked currently; nonsmokers were not smoking currently.
Statistical Methodology
Analyses used the 6-year (1988 to 1994) data from NHANES III and SUDAAN software (Research Triangle Institute, Research Triangle Park, NC), which takes into account the stratified cluster sample design and oversampling of certain population subgroups (33, 42, 43) . National estimates were determined by using sample weights in all analyses. Crude and/or age-adjusted prevalence estimates, means, and SEs are provided by BMI category for nonHispanic white, non-Hispanic black, and Mexican American men and nonpregnant women of Ն20 years of age. Age was adjusted to the estimated year 2000 standard population by the direct method using 10-year age groups. Age-specific estimates are given for ages 20 to 39, 40 to 59, 60 to 79, and Ն80. The sample sizes for 80 and over were small; they were included in the 60 and over age groups in some analyses. SEs were calculated by a technique for complex survey design and estimation procedures (42) . Odds ratios were calculated using logistic regression analyses performed separately for men and women. The models were identical for each risk factor and included direct effects for the categorical variables BMI, race/ethnicity, smoking, and age, and interactions between BMI and race/ethnicity and BMI and age; education was entered as a continuous variable (years of education). To estimate odds ratios incorporating the interaction effects for both sexes from Table 6 , the BMI odds ratio was multiplied by the odds ratios for age or race/ethnicity and by the interaction terms. Reference categories were BMI Ͻ25, non-Hispanic white, nonsmoker, and aged 20 to 39 years as appropriate. Age group and race/ ethnicity were also used as stratifying variables in the figures; odds ratios were estimated separately for each group.
Results
Distribution of BMI
As reported previously (21) , the distribution of BMI varied with sex, race/ethnicity, and age (Table 1) . Greater proportions of women than men had BMIs at the extremes of the distribution (BMI of Ͻ25 and BMI of Ն30). Among men, a smaller proportion of Mexican American men had a BMI of Ͻ25. The proportions of men in the highest BMI category were similar among the three race/ethnic groups. Compared with white women, black and Mexican American women had smaller proportions at the lowest level of BMI and higher proportions at BMI levels of Ͼ27.
The proportion of men and women at the lowest level of BMI (Ͻ25) decreased with increasing age from 20 to 39 years through ages 60 to 79 years. The proportions at the highest BMI level (Ն30) were largest at ages 40 to 59 years. Nearly half of the small numbers of men and women aged 80 and older had a BMI Ͻ25, whereas only 8% of these men and 15% of these women were obese.
Blood Pressure
Mean systolic and diastolic blood pressures increased with increasing BMI in men and women (Table 2) . Systolic blood pressure was ϳ9 mm Hg higher for men (131 vs. 121 mm Hg) and ϳ11 mm Hg higher for women (116 vs. 127 mm Hg) in the highest BMI category (Ն30) compared with the lowest BMI category (Ͻ25). The difference in diastolic blood pressure between the highest BMI category and the lowest BMI category was ϳ7 mm Hg for men and ϳ6 mm Hg for women. The expected higher mean blood pressures at older ages were seen within each BMI category for systolic pressure, but diastolic pressures were lower at ages over 60 years in both sexes.
Among men, the prevalence of high blood pressure increased progressively with increasing BMI, from 15% at a BMI of Ͻ25 to 42% at a BMI of Ն30 (Table 3 ). The trend of higher prevalence of high blood pressure with increasing BMI was similar for white, black, and Mexican American men, but the age-adjusted rates were highest among black men within each level of BMI (see Figure 2 ). The prevalence of high blood pressure increased with age among men at all levels of BMI. The increase in high blood pressure with increasing BMI was greater in the two younger age groups (Table 3 and Figure 1 ). Among men aged 20 to 39 years, the prevalence of high blood pressure was seven times higher at the highest (Ն30) BMI compared with the lowest (Ͻ25) BMI category. Among older men (60 to 79 and over 80) there was a less steep increase in high blood pressure prevalence with increasing BMI category.
Women showed a pattern similar to that of men with respect to prevalence and relationship of high blood pressure to BMI (Table 3 and Figure 1 ). The prevalence of high blood pressure increased progressively from 15% among women with a BMI of Ͻ25 to 38% among women with a BMI of Ն30. The increased prevalence of high blood pressure with increasing BMI was present in white, black, and Mexican American women; however, the age-adjusted prevalence of high blood pressure was highest among black women at every level of BMI ( Figure 2 ). The prevalence of high blood pressure increased with age among women at all levels of BMI. The relationship of high blood pressure with increasing BMI was present in all age groups but it was steeper in the younger age groups (Table 3 and Figure 1 ). At Ͻ60 years of age, women with a BMI of Ն27 had two to four or more times the prevalence of high blood pressure compared with women with a BMI of Ͻ25. Among older women, the prevalence of high blood pressure was generally higher in overweight and obese women than in leaner women. Odds ratios for high blood pressure adjusted for race/ethnicity, education, and current smoking habits are shown for age-specific groups in Figure 3 , where the greater odds ratios for high blood pressure at younger ages are apparent. When BMI, age group, smoking habits and education were in the model, black men and black women had significantly higher prevalences of high blood pressure than white men and women, whereas prevalence rates were significantly lower in Mexican American than white men and women (data not shown). Education was related inversely to the prevalence of high blood pressure in men and women. Women, but not men, who smoked had lower rates of hypertension ( Table 6 ). Interactions of the relationships of BMI with risk factors among age and race/ethnic groups are described below.
Blood Cholesterol
Mean serum cholesterol levels increased with increasing BMI from 193 mg/dL among men at the lowest BMI category to 211 mg/dL in men at the highest category of BMI (Table 4) . Among women, total cholesterol levels increased from 195 mg/dL at the lowest BMI category to 217 mg/dL at the highest BMI level. In both sexes, cholesterol means were consistently lowest at BMIs of Ͻ25 but did not vary much with increasing BMI above 25.
Among men, the prevalence of high blood cholesterol ranged from 13% at the lowest BMI level to 22% at the highest BMI level. The age-adjusted prevalence of high blood cholesterol increased with increasing BMI in white, black, and Mexican American men, but prevalence rates were lower in black and Mexican American men except among obese men. (Table 5 and Figure 2 ). The rise in prevalence of high blood cholesterol associated with increasing BMI was greatest among younger men. Men aged 20 to 39 years with a BMI of Ն27 had more than twice the prevalence of high blood cholesterol as men of that age with a BMI of Ͻ25. A similar but less steep trend was apparent at older ages. At all levels of BMI, the prevalence of high blood cholesterol among men increased from ages 20 to 39 to ages 40 to 59, remained fairly stable in the group aged 60 to 79, and then declined in the oldest age group (Table 5 and Figure 1 ).
The prevalence of high blood cholesterol increased from 13% among women at the lowest BMI level (Ͻ25) to 27% to 30% among women with higher BMI levels; however, there was no consistent rise with increasing BMI above 25 (Table 5 ). Trends were similar for white, black, and Mexican American women. Hypercholesterolemia was generally more prevalent in white than in other women (Figure 2 ). The prevalence of high blood cholesterol among women increased with age, through ages 60 to 79, then decreased at all levels of BMI. The increase in prevalence with increasing BMI was greatest in the younger age groups, and most of the increase occurred from a BMI of Ͻ25 to a BMI of 25 to 27 (Table 5 and Figure 1) .
In regression analyses controlling for race/ethnicity, education, and smoking, the odds ratios for high blood cholesterol were higher at BMIs of Ͼ25 compared with BMIs of Ͻ25 (Figure 3) . Hypercholesterolemia was not related to education or smoking in either sex (Table 6) .
HDL-C
Mean levels of HDL-C were ϳ10 mg/dL higher in women than in men and they decreased with increasing BMI in both sexes ( Table 4 ). The mean HDL-C level for men with BMI Ͻ25 was 50 mg/dL and it declined to 40 mg/dL at a BMI Ն30. Among women, the age-adjusted mean HDL-C level decreased from 59 mg/dL for women with a BMI of Ͻ25 to 49 mg/dL for women with a BMI of Ն30 (Table 4) . Age-adjusted mean HDL-C levels were generally higher in black men and women than in white or Mexican American men or women in all BMI groups (data not shown). The decline with increasing BMI was present among men and women in all race/ethnic groups and age groups.
Among men, the age-adjusted prevalence of low levels of HDL-C (Ͻ35 mg/dL) increased with increasing levels of BMI from 9% to 31% (Table 5) . Black men had the lowest prevalence of low HDL at all levels of BMI (Figure 2) . However, the pattern of increasing prevalence of low HDL with increasing BMI was generally similar among the three race/ethnic groups and among men in all age groups, including those 80 and older.
Among women, the age-adjusted prevalence of low HDL-C (Ͻ45 mg/dL) showed a pattern similar to that in men, increasing from 17% at a BMI of Ͻ25 to 41% at a BMI of Ն30. The prevalence of low HDL-C was lowest among black women; it tended to be higher in Mexican American than white women at every level of BMI. However, the overall pattern of increasing prevalence of low HDL-C with increasing BMI was present among women in all race/ethnic groups and most age groups (Figures 1 and 2 ). There was no consistent stepwise pattern of increasing prevalence of low HDL with increasing age in men or women. Nevertheless, the increase in the prevalence of low levels of HDL-C with increasing BMI was greater in younger men and women, where it was about twice as high in the overweight and three times as high in the obese groups as in the leanest groups (Table 5 and Figure 1) . In regression analyses, low HDL-C was related positively to BMI, white vs. black race, and cigarette smoking; it was related inversely to years of education in women but not in men. Odds ratios for low HDL increased with increasing categories of BMI when race/ethnicity, smoking habits, and years of education were controlled ( Figure 3 and Table 6 ). In age group-specific analyses, odds ratios were highest in the two youngest groups of men and the youngest group of women ( Figure 3 ).
Dyslipidemia
When dyslipidemia was defined as a ratio of total cholesterol to HDL-C of Ն4.5, the prevalence of this condition increased with increasing BMI level in both sexes and all race/ethnic groups. Prevalence rates were lower at ages 20 to 39 and increased with age in women but were lower in the oldest men compared with those aged 40 to 79 years.
Prevalence rates were lower in black men and women compared with other men and women (data not shown).
Hypertension and Dyslipidemia
The percentages of men and women with both high blood pressure and a lipid abnormality are shown in Figure 1 , and the adjusted odds ratios are shown in Table 6 and Figures 2 and 3. The patterns of the combined prevalence of the two risk factors with increasing BMI and age are generally as expected from the patterns present for each risk factor separately; the association of BMI with both conditions together was strong in all analyses. Adjusted odds ratios increased across categories of BMI. Odds ratios for both abnormalities were generally lower in Mexican Americans than in whites or blacks, among women in smokers than nonsmokers, and in women with more education.
Multivariate Odds Ratios
Relationships between BMI and risk factors vary with sex, age, and race/ethnic group as shown in Tables 2  through 5 and Figures 1 through 3 . The results of including interaction terms for BMI and age and for BMI and race/ ethnicity in multivariate models are shown in Table 6 . The effect of BMI on high blood pressure is different for whites, blacks, and Mexican Americans as suggested by inspection of Figure 2 and confirmed by the analysis in Table 6 . For example, the odds ratios for high blood pressure show that the chances of having high blood pressure with a BMI of 25 to 27 compared with a BMI of Ͻ25 is 2.4 times greater at ages 20 to 39 for white men (2.4 ϫ 1.0 ϫ 1.0) and Mexican Based on the comprehensive multivariate analyses shown in Table 6 , the effect of BMI was significant in all models. For men, the direct effects of age and the interaction between BMI and age were significant for high blood pressure and low HDL-C. For women, the direct effects of age and race and the interaction between BMI and age were significant for all risk factors except high blood cholesterol. In addition, the interaction between BMI and race/ethnicity was significant in women for all risk factors except low HDL cholesterol. In the multivariate models, the r 2 coefficients ranged from a high of 0.32 for high blood pressure among women to a low of 0.03 for high blood cholesterol among men. On average, the models accounted for only 10% of the variance of each risk factor among men and only 18% among women.
Discussion
These data show in greater detail the previously described positive relationships of BMI to systolic and diastolic blood pressures, and total cholesterol levels, as well as the negative relationship of BMI to HDL-C levels. In general, the prevalence of hypertension, high blood cholesterol, low HDL-C, and high total cholesterol to HDL-C ratio increase with increasing BMI, as does the combined prevalence of both hypertension and dyslipidemia. These relationships are found among men and women in all race/ethnic groups and in most age groups. Relative risks assessed by odds ratios are greater at younger ages, but prevalences of overweight, obesity, hypertension, and lipid abnormalities are higher at older ages. Odds ratios also vary among race/ethnic groups as indicated by the significant interaction terms. Although the impact of higher levels of BMI on prevalence of high blood pressure, abnormal lipids, and the two abnormalities together varies in terms of magnitude with sex, age, and race/ethnicity, the importance of increasing BMI as a determinant of these conditions is clear.
The inverse relationship between cigarette smoking and weight is well documented (44) , and cigarette smokers have lower levels of HDL-C (45). Thus, failure to control for cigarette smoking will result in an underestimate of the association between BMI and low HDL-C. Cardiovascular risk factors are also known to vary inversely with level of education and to cluster among those with the least amount of education. However, the relationship of BMI with high blood pressure and abnormal lipids persists when smoking habits and education as well as age and race/ethnicity are controlled in regression analyses. In other analyses based on NHANES III data, Must et al. (19) reported increased prevalence ratios by increasing severity of overweight and obesity for several health conditions, including high blood pressure. They also found higher prevalence ratios for high blood cholesterol among overweight and obese men and women than among normal weight persons. These investigators used different categories of BMI, different criteria to define high blood pressure and high blood cholesterol, and different analytic approaches than ours. Although their estimates of prevalence ratios and our odds ratios cannot be compared directly, results of the two studies are strongly concordant in identifying BMI as a risk factor for high blood pressure and high blood cholesterol.
Although cross-sectional studies do not provide information on the sequence of risk factor development, and causeand-effect relationships cannot be inferred, these findings are consistent with the cross-sectional, longitudinal, and clinical studies that show cardiovascular risk factors are more prevalent among overweight and obese people. Crosssectional studies in the United States and other countries have reported such relationships in both sexes, in a variety of ethnic groups, and in children and adults (11, (13) (14) (15) (16) (17) (18) (19) . Associations of adiposity at baseline and incidence of hypertension and dyslipidemia have been shown in large prospective cohort studies (3, 5, 6, 10, 12, 46) . Clinical trials have shown the effect of weight loss on lowering blood pressures and improving lipid values (32, (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) . The science base for concluding that higher levels of body mass are causally related to higher levels of blood pressure and total cholesterol and lower levels of HDL-C is substantial and convincing.
National data show that whereas levels of blood pressure and cholesterol declined and HDL-C generally increased, mean levels of BMI and overweight and obesity increased over recent decades. The decline in mean systolic and diastolic blood pressures between 1976 and 1980 and 1988 and 1991 occurred at all BMI levels (26) . It has been suggested that the declining use of alcohol and dietary salt may have a role in the decline in the prevalence of high blood pressure, despite the increase in obesity (9) . The beneficial trend in cholesterol is probably related to dietary changes (57), because only ϳ2% of the population was using cholesterol-lowering medications during this time period (58) . Previous analyses of the NHANES data have shown that the mean percentage of calories from total dietary fat and from saturated fat decreased from 1976 to 1980 and from 1988 to 1991; however, during that time, reported intake of total calories increased (56) . Changes in calorie intake may reflect increased consumption or improved changes in the dietary protocol to obtain more complete intake information (59) . Increased levels of physical inactivity (60, 61) as well as caloric intakes that are too high in relation to physical activity levels are probable explanations for the rising prevalence of overweight (32) .
Smoking cessation has been shown to be related to weight gain. The prevalence of cigarette smoking has declined dramatically over the past 30 years, and a large proportion of the population has quit smoking (23). Reviews of the relationship between weight gain and smoking cessation have estimated that quitting smoking results in an average weight gain of between 4.5 and 7.5 pounds (50) . From the NHANES III data, estimates of weight gain due to smoking cessation were 10 to 11 pounds. But smoking cessation accounted for only a small part of the recent increase in the prevalence of overweight; approximately one-quarter of the increase among men and approximately one-sixth of the increase among women could be attributed to smoking cessation (62, 63) .
Limitations of this report include the fact that although BMI is highly correlated with body fatness (0.7 to 0.8) (64), it measures lean body mass as well as fat mass. It has been suggested that central, particularly visceral, fat is a more important contributor to cardiovascular risk than total body fat. Measures of regional adiposity such as waist circumference, waist-to-hip ratio, and subscapular to triceps skinfold thickness correlate highly with other measures of overweight such as BMI and may be even more strongly correlated with lipoprotein cholesterol fractions (64) . However, the BMI-risk factor relationships have been shown to be independent of the measures used to characterize body weight or fat distribution. Some variability in the association of BMI and risk factors by sex, race/ethnic, and age groups is to be expected, given biological variability in blood pressure, total cholesterol, and HDL-C, and the importance of factors such as heredity, diet, and exercise, which are known to influence these variables.
The adverse relationship between BMI and cardiovascular risk factors is likely to be understated in these analyses because information on diabetes was not considered. Recent reports implicating overweight as a potent factor in the etiology of type 2 diabetes include an analysis of NHANES III data in which prevalence ratios for diabetes increased steeply with increasing levels of BMI; they were 2 to 18 times higher in obese than normal weight men and women, depending on the severity of obesity (19) . A study of middle-aged women found that a BMI of 23 to 25 was associated with a fourfold increase in risk for diabetes mellitus compared with a BMI Ͻ22. These reports suggest that optimal weight for height may be lower than a BMI of 25 (46, 65) , but being underweight is also associated with excess morbidity and mortality (19, 20, 32) .
Conclusion
The high prevalence of overweight is a major public health problem in the United States. Thirty-nine million Americans are estimated to have a BMI of Ն30 and an additional 57 million to have a BMI of 25 to 29.9. This study quantifies for a representative national sample of the adult population the distribution of BMI, the relationship between BMI and blood pressure and lipid levels, and the excess prevalence of hypertension and dyslipidemia, separately and in combination among persons with a BMI of Ն25. These findings indicate that levels of cardiovascular risk factors are substantially lower at a BMI of Ͻ25 than at higher BMI levels and suggest that levels of BMI that are used to define optimal weight, overweight, and obesity should take into account the strong and consistent relationships between BMI and cardiovascular risk factors and other health-related characteristics. Applying these prevalence estimates to the population yields estimates that 28 million Americans are obese (BMI of Ͼ30) and have high blood pressure, dyslipidemia, or both. Among those who are overweight (BMI of 25 to 29.9), 37 million have hypertension, dyslipidemia, or both conditions. Relative risks (indicated by odds ratios) and absolute risks (indicated by prevalence rates) are both important in determining clinical practice and public health approaches to case finding, treatment, and prevention of overweight, obesity, high blood pressure, lipid abnormalities, and related conditions.
